Accompanying therapy in oncohematological patients with secondary immunodeficiency
Actuality. The inability of a persons immune system to withstand foreign antigenic aggression is called immunodeficiency. More than 1/2 of all cases of secondary immunodeficiency (SID) in the world are occupied by hemoblastosis and, in a greater degree, the therapy, accompanied by the immunosuppress...
Guardado en:
Autores principales: | Lali G. Babicheva, Irina V. Poddubnaya |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Habib O.N.
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a65ffe348f149f987d8d324d766a5b1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Features of management of oncohematological patients in the context of the COVID-19 pandemic
por: I. V. Poddubnaya, et al.
Publicado: (2020) -
First-line therapy of indolent non-Hodgkin’s lymphoma in routine clinical practice
por: Lali G. Babicheva, et al.
Publicado: (2020) -
Maintenance oncohematological patients and new coronavirus infection: experience of the City Clinical Hospital №52
por: Elena A. Baryakh, et al.
Publicado: (2020) -
Necrolisis epidérmica tóxica. Terapia en UCI con inmunoglobulinas intravenosas en un caso
por: Andresen H,Max, et al.
Publicado: (2000) -
The long-term survival outcomes of gastric cancer patients with total intravenous anesthesia or inhalation anesthesia: a single-center retrospective cohort study
por: Wei-Wei Wu, et al.
Publicado: (2021)